![Daniel Hetu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Hetu
Corporate Officer/Principal chez
LAVA MEDTECH ACQUISITION CORP.
Profil
Daniel Hetu is currently a Managing Director at Lumira Capital Investment Management, Inc. He also holds director positions at Gladius Pharmaceuticals, Inc., Gladius Pharmaceuticals Corp., Xylocor Therapeutics, Inc., Kisoji Biotechnology, Inc., Transposon Therapeutics, Inc., Specific Biologics, Inc., Congruence Therapeutics, Inc., and is an Executive Vice President at LAVA Medtech Acquisition Corp.
In the past, Dr. Hetu has worked as a Director at Cardiac Dimensions, Inc., Resonant Medical, Inc., U-Systems, Inc., Réseau Capital, IMV, Inc., Thrasos Therapeutics, Inc., and Opsens Medical.
He was also a Director and Vice President at OsteoqQC, Inc. from 2014 to 2022.
Additionally, he held positions as Vice President of Corporate Development at Biochem Pharma, Inc. and Vice President of Business Development at Shire Pharmaceuticals, Inc.Dr. Hetu holds a doctorate degree from the University of Sherbrooke and an MBA from École des Hautes Études Commerciales de Paris.
Postes actifs de Daniel Hetu
| Sociétés | Poste | Début |
|---|---|---|
| LAVA MEDTECH ACQUISITION CORP. | Corporate Officer/Principal | - |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Private Equity Investor | 01/01/2005 |
Kisoji Biotechnology, Inc.
 Kisoji Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cancer therapeutics through antibodies and stem cells | Directeur/Membre du Conseil | - |
Transposon Therapeutics, Inc.
 Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Directeur/Membre du Conseil | - |
Congruence Therapeutics, Inc.
 Congruence Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Directeur/Membre du Conseil | - |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Directeur/Membre du Conseil | - |
Gladius Pharmaceuticals Corp.
 Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Operates as biotechnology firm | Directeur/Membre du Conseil | - |
Gladius Pharmaceuticals, Inc.
 Gladius Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops biotechnology novel drugs | Directeur/Membre du Conseil | - |
Specific Biologics, Inc.
 Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body | Directeur/Membre du Conseil | - |
Anciens postes connus de Daniel Hetu
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Daniel Hetu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
39
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Cardiac Dimensions, Inc.
 Cardiac Dimensions, Inc. Medical SpecialtiesHealth Technology Develops novel interventional tools for the treatment of heart failures | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
Biochem Pharma, Inc.
 Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Develops pharmaceutical products focused on infectious diseases and cancer | Health Technology |
Resonant Medical, Inc.
 Resonant Medical, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and distributes 3D ultrasound image-guided adaptive radiotherapy products | Health Technology |
U-Systems, Inc.
 U-Systems, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets ultrasound systems | Health Technology |
University of Sherbrooke
 University of Sherbrooke Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Réseau Capital
 Réseau Capital Miscellaneous Commercial ServicesCommercial Services Operates as a venture capital and private equity association | Commercial Services |
IMV, Inc.
 IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Thrasos Therapeutics, Inc.
 Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotheraputics for the treatment and prevention of kidney diseases | Health Technology |
Gladius Pharmaceuticals, Inc.
Gladius Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops biotechnology novel drugs | Health Technology |
Gladius Pharmaceuticals Corp.
Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Operates as biotechnology firm | Health Technology |
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel gene therapy for cardiovascular disease | Health Technology |
Opsens Medical
 Opsens Medical Electrical ProductsProducer Manufacturing Manufactures nitinol-based fiber optic pressure sensing guidewire for the diagnosis and treatment of coronary and peripheral artery diseases | Producer Manufacturing |
Kisoji Biotechnology, Inc.
Kisoji Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cancer therapeutics through antibodies and stem cells | Health Technology |
OsteoqQC, Inc.
 OsteoqQC, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of bone-related diseases | Health Technology |
Transposon Therapeutics, Inc.
Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body | Commercial Services |
Congruence Therapeutics, Inc.
Congruence Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
LAVA Medtech Acquisition Corp.
 LAVA Medtech Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
